High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy
CRD SUMMARY: The authors concluded that high-dose N-acetylcysteine decreased the incidence of contrast-induced nephropathy. This was a generally well-conducted review and the authors' conclusions are likely to be reliable.
